DURECT Corporation (DRRX)
NASDAQ: DRRX · IEX Real-Time Price · USD
0.659
-0.001 (-0.15%)
At close: Nov 27, 2023, 4:00 PM
0.639
-0.021 (-3.11%)
Pre-market: Nov 28, 2023, 4:58 AM EST
DURECT Market Cap
DURECT has a market cap or net worth of $19.66 million as of November 28, 2023. Its market cap has decreased by -82.46% in one year.
Market Cap
19.66M
Enterprise Value
3.83M
1-Year Change
-82.46%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since September 28, 2000, DURECT's market cap has decreased from $660.10M to $19.66M, a decrease of -97.02%. That is a compound annual growth rate of -14.07%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 24, 2023 | 19.70M | 1.55% |
Nov 22, 2023 | 19.40M | 3.19% |
Nov 21, 2023 | 18.80M | -2.59% |
Nov 20, 2023 | 19.30M | 5.46% |
Nov 17, 2023 | 18.30M | 0.55% |
Nov 16, 2023 | 18.20M | - |
Nov 15, 2023 | 18.20M | 12.35% |
Nov 14, 2023 | 16.20M | 11.72% |
Nov 13, 2023 | 14.50M | -0.68% |
Nov 10, 2023 | 14.60M | -7.59% |
Nov 9, 2023 | 15.80M | 8.97% |
Nov 8, 2023 | 14.50M | -79.63% |
Nov 7, 2023 | 71.20M | -0.42% |
Nov 6, 2023 | 71.50M | -5.05% |
Nov 3, 2023 | 75.30M | 1.48% |
Nov 2, 2023 | 74.20M | -9.73% |
Nov 1, 2023 | 82.20M | 8.30% |
Oct 31, 2023 | 75.90M | 10.48% |
Oct 30, 2023 | 68.70M | 11.17% |
Oct 27, 2023 | 61.80M | -4.33% |
Oct 26, 2023 | 64.60M | -1.22% |
Oct 25, 2023 | 65.40M | -3.68% |
Oct 24, 2023 | 67.90M | -0.73% |
Oct 23, 2023 | 68.40M | -3.39% |
Oct 20, 2023 | 70.80M | -12.16% |
View and export this data all the way back to 2000.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Acasti Pharma | 20.26M |
Elevation Oncology | 20.23M |
PharmaCyte Biotech | 20.19M |
Viracta Therapeutics | 19.70M |
Lisata Therapeutics | 19.70M |
Unicycive Therapeutics | 19.52M |
China SXT Pharmaceuticals | 19.43M |
Gyre Therapeutics | 19.42M |